This inventor holds 1 USPTO granted patent. Top assignee: Sartorius Stedim North America Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Thomas Mickleburgh: Innovator in Biopharmaceutical Stability Evaluation
Introduction
Thomas Mickleburgh is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the evaluation of stability for various compositions. His innovative approach has led to the development of a unique patent that addresses critical challenges in the industry.
Latest Patents
Mickleburgh holds a patent for a "Small volume system and methods of evaluating the stability of biopharmaceutical compositions." This invention features an analysis container that includes an outer tube and multiple inner tubes. The outer tube defines a buffer volume designed to receive a buffer material, while the inner tubes, each with an inner diameter of 6 mm or less, are configured to hold a biopharmaceutical composition. The design allows for the axial freezing of both the buffer material and the biopharmaceutical composition, enhancing the evaluation process.
Career Highlights
Currently, Thomas Mickleburgh is employed at Sartorius Stedim North America Inc., where he continues to innovate and contribute to advancements in biopharmaceutical technologies. His work is characterized by a commitment to improving the stability and efficacy of biopharmaceutical products.
Collaborations
Mickleburgh collaborates with his coworker, Nicholas Phillips, to further enhance their research and development efforts. Their combined expertise fosters a productive environment for innovation in their field.
Conclusion
Thomas Mickleburgh's contributions to biopharmaceutical stability evaluation through his patented invention exemplify the impact of innovative thinking in the industry. His work at Sartorius Stedim North America Inc. continues to pave the way for advancements in biopharmaceutical technologies.